CA2633918A1 - Substituted imidazoline derivatives - Google Patents

Substituted imidazoline derivatives Download PDF

Info

Publication number
CA2633918A1
CA2633918A1 CA002633918A CA2633918A CA2633918A1 CA 2633918 A1 CA2633918 A1 CA 2633918A1 CA 002633918 A CA002633918 A CA 002633918A CA 2633918 A CA2633918 A CA 2633918A CA 2633918 A1 CA2633918 A1 CA 2633918A1
Authority
CA
Canada
Prior art keywords
dihydro
imidazole
carboxylic acid
methyl ester
acid methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002633918A
Other languages
English (en)
French (fr)
Inventor
Beatrix Merla
Stefan Oberboersch
Bernd Sundermann
Werner Englberger
Hagen-Heinrich Hennies
Heinz Graubaum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2633918A1 publication Critical patent/CA2633918A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002633918A 2005-12-22 2006-12-19 Substituted imidazoline derivatives Abandoned CA2633918A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005061430A DE102005061430A1 (de) 2005-12-22 2005-12-22 Substituierte Imidazolin-Derivate
DE102005061430.2 2005-12-22
PCT/EP2006/012221 WO2007079927A1 (de) 2005-12-22 2006-12-19 Substituierte imidazolin-derivate

Publications (1)

Publication Number Publication Date
CA2633918A1 true CA2633918A1 (en) 2007-07-19

Family

ID=37946192

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002633918A Abandoned CA2633918A1 (en) 2005-12-22 2006-12-19 Substituted imidazoline derivatives

Country Status (17)

Country Link
US (1) US7728028B2 (enExample)
EP (1) EP1963278B1 (enExample)
JP (1) JP2009523124A (enExample)
CN (1) CN101384557A (enExample)
AT (1) ATE449075T1 (enExample)
AU (1) AU2006334743B2 (enExample)
CA (1) CA2633918A1 (enExample)
CY (1) CY1110465T1 (enExample)
DE (2) DE102005061430A1 (enExample)
DK (1) DK1963278T3 (enExample)
ES (1) ES2336833T3 (enExample)
IL (1) IL192268A0 (enExample)
PL (1) PL1963278T3 (enExample)
PT (1) PT1963278E (enExample)
RU (1) RU2427571C2 (enExample)
SI (1) SI1963278T1 (enExample)
WO (1) WO2007079927A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2257526T3 (pl) 2008-03-27 2012-05-31 Gruenenthal Gmbh Pochodne spiro (5.5) undekanu
US8357705B2 (en) 2008-03-27 2013-01-22 Gruenenthal Gmbh Substituted cyclohexyldiamines
ES2694103T3 (es) 2008-03-27 2018-12-18 Grünenthal GmbH Derivados de 4-aminociclohexano sustituidos
CL2009000731A1 (es) 2008-03-27 2009-05-15 Gruenenthal Gmbh Compuestos derivados de ciclohexano espirociclicos sustituidos, composicion farmaceutica que contiene a dicho compuesto y su uso como moduladores del receptor de opioides µ y el receptor orl-1 para tratar el dolor, ansiedad, depresion, epilepsia, alzheimer, abuso de alcohol, hipertension, anorexia, obesidad y diarrea.
JP5599774B2 (ja) 2008-03-27 2014-10-01 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング ヒドロキシメチルシクロヘキシルアミン類
HUE026184T2 (en) 2008-03-27 2016-05-30 Gruenenthal Gmbh (Hetero-) aryl-cyclohexane derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9034798A (en) * 1997-08-28 1999-03-16 Eli Lilly And Company Method for treating pain
US5952360A (en) * 1997-08-28 1999-09-14 Eli Lilly And Company Method for treating neuropathic pain
DE10000312A1 (de) * 2000-01-05 2001-07-12 Gruenenthal Gmbh Substituierte Aminomethyl-Phenyl-Cyclohexanderivate
US7183276B2 (en) * 2002-02-28 2007-02-27 Takeda Pharmaceutical Company Limited Azole compounds
US6878735B2 (en) * 2002-05-31 2005-04-12 Board Of Trustees Of Michigan State University Multi-substituted imidazolines and method of use thereof
US7345078B2 (en) * 2002-05-31 2008-03-18 The Board Of Trustees Of Michigan State University NF-κB inhibitors and uses thereof
DE102005061429A1 (de) * 2005-12-22 2007-06-28 Grünenthal GmbH Substituierte Oxazol-Derivate

Also Published As

Publication number Publication date
PT1963278E (pt) 2009-12-16
SI1963278T1 (sl) 2010-03-31
DE502006005426D1 (de) 2009-12-31
EP1963278B1 (de) 2009-11-18
US20090048323A1 (en) 2009-02-19
ATE449075T1 (de) 2009-12-15
AU2006334743A1 (en) 2007-07-19
RU2427571C2 (ru) 2011-08-27
CN101384557A (zh) 2009-03-11
US7728028B2 (en) 2010-06-01
WO2007079927A1 (de) 2007-07-19
CY1110465T1 (el) 2015-04-29
AU2006334743B2 (en) 2011-07-07
HK1122019A1 (zh) 2009-05-08
EP1963278A1 (de) 2008-09-03
IL192268A0 (en) 2008-12-29
DE102005061430A1 (de) 2007-07-05
DK1963278T3 (da) 2010-03-29
JP2009523124A (ja) 2009-06-18
PL1963278T3 (pl) 2010-04-30
RU2008129377A (ru) 2010-03-27
ES2336833T3 (es) 2010-04-16

Similar Documents

Publication Publication Date Title
RU2503660C2 (ru) Замещенные производные 4-аминоциклогексана
US8124788B2 (en) Spirocyclic cyclohexane compounds with analgesic activity
NZ568285A (en) 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between P53 and MDM2 proteins for use as anticancer agents
RU2440344C2 (ru) Применение 2-имидазолов для лечения расстройств цнс
AU2006215567B2 (en) 1H-imidazole derivatives as cannabinoid CB2 receptor modulators
AU2008270445A1 (en) 2 -imidazolines having a good affinity to the trace amine associated receptors (TAARs)
BRPI0718059A2 (pt) Aminometil-2-imidazóis com afinidade com os receptores amina-associado traço
US7728028B2 (en) Substituted imidazoline compounds
US20100204233A1 (en) Imidazole derivatives
US7608619B2 (en) Substituted oxazole compounds with analgesic activity
CA2563017C (en) Substituted cyclohexylacetic acid derivatives
ES2411508T3 (es) Derivados de oxadiazol sustituidos y su utilización como ligandos de los receptor opioides
AU2004283903B2 (en) 1H-imidazole derivatives as cannabinoid receptor modulators
CA2562539C (en) Substituted cyclohexylcarboxylic acid derivatives
MX2008008067A (en) Substituted imidazoline derivatives
HK1122019B (en) Substituted imidazoline derivatives

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20131219